Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2013-11-21

Clinical Trial Update: Management of Hyperglycemia in the ER: A Randomized Clinical Trial of a Subcutaneous Insulin Aspart Protocol Coupled With Rapid Initiation of Basal Bolus Insulin Prior to Hospital Admission Versus Usual Care [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial evaluating a subcutaneous insulin aspart protocol with rapid initiation of a basal-bolus insulin regimen before hospital admission ve…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin aspart (insulin aspart)
  • basal insulin regimen (basal insulin regimen)

Snippet

Sponsor: Emory University | Conditions: Diabetes | Phase 4 | Status: WITHDRAWN